Poly(ADP-Ribosyl)ation
|
Email this
Print this
Alexander Burkle
This book is co-published with Springer.
Please click here to purchase this book at the Springer site. ISBN: 978-0-387-33371-7 Pub date: 2006-04-28 246 pages 77 figures 16 tables |
About this bookThe research field of poly(ADP-ribosyl)ation, which originated in the mid-1960s as an extremely narrow focus of interest for polynucleotide biochemists, has remained a rather stable field for a long time in terms of scientific orientation and researchers involved. Starting from the late 1980s, however, the scene has witnessed a tremendous influx of new people, fresh ideas and novel techniques, which led—especially over the last five years—to a breathtaking expansion of the field with regards to breadth and depth of scientific information available. What began as a peculiar posttranslational modification somehow associated with DNA repair has now invaded almost all sub-disciplines of biology and has also gained substantial interest by medical researchers and pharmaceutical companies, as there is a wide range of pathophysiological conditions linked with poly(ADP-ribosyl)ation. Poly(ADP-Ribosyl)ation comprises 19 chapters written by leading international experts in the field and is richly illustrated. Extensive bibliography is given in each chapter. |
|
Table of contents1. Enzymes in Poly(ADP-Ribose) Metabolism 2. PARP-2: Structure-Function Relationship 3. Targeting the Poly(ADP-Ribose) Glycohydrolase (PARG) Gene in Mammals 4. DNA Damage Signaling through Poly(ADP-Ribose) 5. Roles of Poly(ADP-Ribose) Metabolism in the Regulation of Centrosome
6. Functional Interactions of PARP-1 with p53 7. Dynamic Interaction between PARP-1, PCNA and p21(waf1/cip1) 8. PARP-1 as Novel Coactivator of NF-kB in Inflammatory
Disorders 9. PARP and Epigenetic Regulation 10. PARP and the Release of Apoptosis-Inducing Factor from Mitochondria
11. Genome Degradation by DNAS1L3 Endonuclease: A Key PARP-1-Regulated 12. NAD-Metabolism and Regulatory Functions 13. PARP-1 and the Shape of Cell Death 14. Poly(ADP-Ribose) Polymerase (PARP) and Excitotoxicity 15. Poly(ADP-Ribose) Polymerase and Ischemia-Reperfusion Injury 16. Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis 17. Role of Poly-ADP-Ribosylation in Cancer Development 18. PARP Inhibitors and Cancer Therapy 19. Poly(ADP-Ribosyl)ation and Aging |
|
Email this
Print this